Detection device, detection method, and heating device
The detection device automates the amplification and detection of nucleic acids using an isothermal method and chromatography paper, addressing the reliance on user skill in genetic testing and enhancing the accuracy and reliability of pathogen detection.
Patent Information
- Application Number
- PCT/JP2024/016682
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-08
- Filing Date
- 2024-04-30
- Publication Date
- 2024-11-14
AI Technical Summary
Current genetic testing methods for detecting pathogens rely heavily on user skill, making them prone to inaccuracies due to variations in handling samples and reagents, which can affect the amplification and detection of nucleic acids.
A detection device that includes a sample placement member, an amplification member with immobilized reagents, and a supply path for amplified nucleic acids, allowing for automated mixing and detection without requiring specialized user skills, using an isothermal nucleic acid amplification method like LAMP and a chromatography paper-based detection system that changes color upon detecting amplified nucleic acids.
The device enables accurate and skill-independent detection of nucleic acids, reducing human error and improving the reliability of pathogen detection by automating the amplification and detection processes, allowing for easy visualization of results through color change on chromatography paper.
Smart Images

Figure JP2024016682_14112024_PF_FP_ABST
Abstract
Description
Detection device, detection method, and heating device
[0001] The present invention relates to a detection device, a detection method, and a warming device.
[0002] Genetic testing is a method for simply determining whether or not a subject is infected with a pathogen by using nucleic acid (DNA or RNA) such as a gene.
[0003] Genetic testing methods detect nucleic acids (hereinafter referred to as "amplified nucleic acids") produced by amplifying nucleic acids (hereinafter referred to as "target nucleic acids") derived from microorganisms (e.g., bacteria, fungi, viruses) contained in a sample collected from a subject (e.g., the subject's saliva).
[0004] A user (e.g., a medical professional) who performs the genetic testing method performs a step of amplifying a target nucleic acid (hereinafter referred to as the "amplification step") and a step of detecting the amplified nucleic acid (hereinafter referred to as the "detection step"). The user performs pipetting to mix samples and reagents in each of the amplification step and detection step.
[0005] Users are required to have specialized knowledge and skills regarding the mixing of samples and reagents, meaning that the accuracy of genetic testing depends on the skill of the user.
[0006] Detecting devices for detecting whether or not a sample contains a target substance have been proposed (see, for example, Patent Document 1).
[0007] International Publication No. 2022 / 070662
[0008] An object of the present invention is to provide a detection device that can detect nucleic acids without depending on the skill of the user, a detection method using the detection device, and a heating device that heats the detection device.
[0009] The detection device of the present invention is a detection device that detects amplified nucleic acid generated from a target nucleic acid contained in a sample, and is characterized in that it comprises a sample placement member on which the sample is placed, a test piece used to detect the amplified nucleic acid, an amplification member on which a reagent used to generate amplified nucleic acid from the target nucleic acid is immobilized, and a supply path that supplies the amplified nucleic acid toward the test piece, and the amplification member is placed in the supply path.
[0010] The present invention can provide a detection device capable of detecting nucleic acids without depending on the skill of the user, a detection method using the detection device, and a heating device for heating the detection device.
[0011] 1 is a schematic diagram showing the relationship between a sample, a reagent, and a developing solution used in a detection device according to the present invention. FIG. 1 is a perspective view of the detection device showing an embodiment of the detection device. FIG. 2 is an exploded perspective view of the detection device of FIG. 2. FIG. 3 is a schematic diagram showing an amplification member inserted into a first supply channel of the detection device of FIG. 2. FIG. 4 is a schematic diagram showing the detection device of FIG. 2 before a heater is attached. FIG. 5 is a schematic diagram showing the detection device of FIG. 2 after a heater is attached. FIG. 6 is an exploded perspective view of the detection device showing another embodiment of the detection device. FIG. 7 is a schematic diagram showing the second button of the detection device of FIG. 2 or FIG. 7 being operated. FIG. 8 is a schematic diagram showing the amplification member of the detection device of FIG. 2 or FIG. 7 being connected to chromatography paper of the detection device. FIG. 9 is a schematic diagram showing another embodiment of a detection device according to the present invention, showing the second button of the detection device being operated. FIG. 10 is a schematic diagram showing the amplification member of the detection device of FIG. 10 being connected to chromatography paper of the detection device. FIG. 11 is a schematic diagram showing yet another embodiment of a detection device according to the present invention, showing the second button of the detection device being operated. FIG. 12 is a schematic diagram showing the amplification member of the detection device of FIG. 12 being connected to chromatography paper of the detection device. 16 is a schematic diagram showing yet another embodiment of a detection device according to the present invention, illustrating a state in which the second button of the detection device is operated. 17 is a schematic diagram showing a state in which the amplification member of the detection device of FIG. 14 is connected to the chromatography paper of the detection device. 18 is a schematic diagram showing an embodiment of a warming device according to the present invention. 19 is a schematic diagram showing a state in which the first button presser and the second button presser of the warming device and the motor rotating shaft rotate, as seen from the motor side of the warming device of FIG. 16. 20 is a schematic diagram showing a state in which the first button and the second button of the detection device of FIG. 7 are pressed by the first button presser and the second button presser of the warming device of FIG. 16, respectively.
[0012] Embodiments of the detection device (hereinafter referred to as "the device"), detection method (hereinafter referred to as "the method"), and warming device (hereinafter referred to as "the warming device") according to the present invention will be described below with reference to the drawings.
[0013] The following is an example of how the device is used to determine whether a subject is infected with a specific pathogen (e.g., influenza virus). When a sample collected from a subject contains nucleic acid derived from the specific pathogen, the device uses chromatography paper to detect the amplified nucleic acid produced by amplifying the nucleic acid. The chromatography paper changes color when it detects the amplified nucleic acid. A user of the device (e.g., a medical professional or subject) determines whether the subject is infected with the specific pathogen based on whether the chromatography paper changes color.
[0014] Here, nucleic acid derived from a specific pathogen is an example of a target nucleic acid in the present invention. Saliva collected from a subject is an example of a sample in the present invention. Chromatography paper is an example of a test strip in the present invention.
[0015] 1 is a schematic diagram showing the relationship between the sample, reagents, and developer used in this device, showing an example in which a subject is infected with a specific pathogen.
[0016] The figure shows that a target nucleic acid is contained in a sample. The figure shows that the sample is mixed with a reagent. The figure shows that an amplification solution is produced as a result of this mixing. The figure shows that the amplification solution contains amplified nucleic acid. The figure shows that the amplification solution is mixed with a developer solution. The figure shows that a detection solution is produced as a result of this mixing. The figure shows that the detection solution contains amplified nucleic acid. The figure shows that the detection solution is supplied to a test strip.
[0017] Saliva is a sample collected from a subject to determine whether the subject is infected with a specific pathogen. When the subject is infected with the specific pathogen, the saliva contains a target nucleic acid. When the subject is not infected with the specific pathogen, the saliva does not contain the target nucleic acid. The saliva used in this device may be saliva itself, or saliva diluted with saline containing an RNase inhibitor or a denaturant.
[0018] The reagent is a reagent used for amplifying a target nucleic acid. The method for amplifying a target nucleic acid in the present invention is an isothermal nucleic acid amplification method. The method for amplifying a target nucleic acid in this embodiment is a LAMP (Loop-mediated Isothermal Amplification) method, which is a type of isothermal nucleic acid amplification method. The reagent in this embodiment is a LAMP reagent.
[0019] The amplification liquid is a liquid produced by the reaction between the sample and the reagent. The amplification liquid contains amplified nucleic acid when the sample contains the target nucleic acid. The amplification liquid does not contain amplified nucleic acid when the sample does not contain the target nucleic acid.
[0020] The developing solution is a medium (liquid) for moving the amplified nucleic acid toward the chromatography paper. In this embodiment, the developing solution is a mixture of water, phosphate buffer, sodium chloride, a surfactant such as Tween 20, and bovine serum albumin.
[0021] The detection solution is a liquid supplied to the chromatography paper. The detection solution is generated by mixing the amplification solution with the developing solution. The detection solution contains amplified nucleic acid when the amplification solution contains amplified nucleic acid. The detection solution does not contain amplified nucleic acid when the amplification solution does not contain amplified nucleic acid.
[0022] The target nucleic acid is a nucleic acid derived from a specific pathogen that may be contained in the sample. The target nucleic acid is a nucleic acid that is the target of amplification by the present device.
[0023] The amplified nucleic acid is the target nucleic acid amplified by the present device, and is the nucleic acid to be detected by the present device.
[0024] First Embodiment of the Present Device and Method The following is an example in which the presence or absence of infection with any of four specific pathogens is determined from a single sample (saliva). The saliva may contain four types of target nucleic acids corresponding to each of the four specific pathogens. The four types of target nucleic acids are examples of the first nucleic acid, second nucleic acid, third nucleic acid, and fourth nucleic acid of the present invention.
[0025] This device includes four types of reagents. Each reagent corresponds to one of four types of target nucleic acids. Each reagent amplifies the corresponding target nucleic acid. As a result, each reagent generates an amplified nucleic acid from the corresponding target nucleic acid. The four types of reagents are examples of the first reagent, second reagent, third reagent, and fourth reagent of the present invention.
[0026] The reagents are placed in flexible tubes (hereinafter referred to as "tubes") that serve as saliva supply channels. The device includes four tubes. Each of the four types of reagents is placed in a different tube. That is, the reagent placed in each tube is different.
[0027] Configuration of the device (1) Figure 2 is a perspective view of the device, showing an embodiment of the device. Figure 3 is an exploded perspective view of the device.
[0028] The device 1 includes a cover 10 and a base 20 .
[0029] The cover 10, together with the base 20, constitutes the housing of the device 1. The cover 10 is disposed above the base 20 and attached to the base 20. The internal space of the housing is sealed.
[0030] The cover 10 includes an upper heater insertion hole 11, a cap 12, a first button 13, a first window 14, a second button 15, a second window 16, a sample introduction hole 17, a developing solution tank 18, and a water absorbent body 19.
[0031] The base 20 includes a lower heater insertion hole 21, a sample receiver 22, a needle 23, a tube mounting member 24, tubes 25-28, chromatography paper 29, and amplification members 50-53 (see FIG. 4).
[0032] The upper heater insertion hole 11 is a hole into which a heating means for heating the tubes 25 to 28 is inserted. The upper heater insertion hole 11 is disposed on the side surface of the cover 10.
[0033] The cap 12 is a plug that seals the sample introduction hole 17. The cap 12 is an example of a sealing member in the present invention.
[0034] The first button 13 is a button that places the developing liquid in the sample receiver 22. The first button 13 is equipped with a developing liquid tank 18. When the first button 13 is pressed by a user, the first button 13 moves the developing liquid tank 18 downward. The first button 13 is an example of a movement operating member in the present invention.
[0035] The first window 14 is a window that allows the inside of the cover 10 to be viewed from the outside of the cover 10. The first window 14 is disposed above the tubes 25-28. A user can visually determine through the first window 14 whether the tubes 25-28 are being heated by the heating means. The first window 14 is an example of an amplification observation window in the present invention.
[0036] The second button 15 is a button for disposing the water absorbent body 19 between the tubes 25-28 and the chromatography paper 29. In other words, the water absorbent body 19 is disposed between the tubes 25-28 and the chromatography paper 29. The second button 15 is an example of a supply operation member according to the present invention.
[0037] The second window 16 is a window that allows the inside of the cover 10 to be seen from the outside of the cover 10. The second window 16 is disposed above the chromatography paper 29. That is, the second window 16 faces the chromatography paper 29. That is, the second window 16 faces a color-developing surface, which will be described later. The second window 16 is disposed in the cover 10. A user can visually determine whether the chromatography paper 29 is colored or not through the second window 16. The second window 16 is an example of a detection observation window in the present invention.
[0038] The sample introduction hole 17 is a hole through which saliva is introduced to be placed in the sample receiver 22. The saliva is placed in the sample receiver 22 from outside the device 1 via the sample introduction hole 17.
[0039] The developing liquid tank 18 is a tank that stores the developing liquid.
[0040] The water absorbent body 19 supplies the detection liquid produced in the tubes 25-28 to the chromatography paper 29. The water absorbent body 19 is a highly absorbent material (e.g., a sponge) that absorbs the detection liquid. The water absorbent body 19 has a first contact portion 191 and a second contact portion 192. The water absorbent body 19 absorbs the detection liquid produced in the tubes 25-28 from the first contact portion 191. The water absorbent body 19 supplies the absorbed detection liquid from the second contact portion 192 to the chromatography paper 29. The water absorbent body 19 is an example of a second supply path in the present invention.
[0041] The base 20 and the cover 10 form the housing of the device 1 .
[0042] The lower heater insertion hole 21 is a hole into which a heating means for heating the tubes 25-28 is inserted. The lower heater insertion hole 21 is arranged on the side surface of the base 20. The lower heater insertion hole 21 is arranged below the upper heater insertion hole 11.
[0043] The sample receiver 22 is a tray on which the saliva from the sample introduction hole 17 and the developing solution from the developing solution tank 18 are placed. The sample receiver 22 is an example of a sample placement member in the present invention.
[0044] The needle 23 is a needle that breaks a part of the developer tank 18. The needle 23 is an example of a breaking member according to the present invention.
[0045] The needle 23 constitutes the ejection means of the present invention together with the first button 13. That is, in this embodiment, the ejection means includes the first button 13 and the needle 23.
[0046] The tube mounting member 24 is a member that mounts the tubes 25-28 to the base 20.
[0047] Tube 25-28 is a supply channel that supplies the amplified nucleic acid toward chromatography paper 29. Tube 25-28 is a reaction vessel for saliva and a reagent. Tube 25-28 is made of an elastomer, such as rubber, polyurethane, or silicone. The target nucleic acid contained in the saliva reacts with the reagent in tube 25-28 and is amplified. As a result, amplified nucleic acid is produced in tube 25-28. Tube 25-28 is an example of a first supply channel in the present invention. Tube 25-28 is an example of a first, second, third, and fourth tubular body in the present invention.
[0048] The chromatography paper 29 is a detection paper for detecting amplified nucleic acid. One end (not shown) of the chromatography paper 29 on the second contact portion 192 side is the upstream end. The other end (not shown) of the chromatography paper 29 is the downstream end. The chromatography paper 29 includes a color developer, a capture agent, and a color-developing surface. The chromatography paper 29 is an example of a test strip according to the present invention.
[0049] The coloring agent is a dye that causes the chromatography paper 29 to develop a color. The coloring agent binds to the amplified nucleic acid. The chromatography paper 29 includes a coloring agent for each amplified nucleic acid to be bound. The chromatography paper 29 includes four coloring agents. Each of the four coloring agents is disposed at a different position on the chromatography paper 29. The coloring agent is disposed on the upstream end side of the capture agent. The coloring agent in this embodiment is a colored bead. The four coloring agents are examples of the first coloring agent, second coloring agent, third coloring agent, and fourth coloring agent of the present invention.
[0050] The capture agent is a substance that captures amplified nucleic acid. The capture agent captures amplified nucleic acid bound to a color developer. The chromatography paper 29 includes a capture agent for each amplified nucleic acid to be captured. The chromatography paper 29 includes four capture agents. Each of the four capture agents is disposed at a different position on the chromatography paper 29. The capture agent is disposed on the downstream end side of the color developer. The four capture agents are examples of the first capture agent, second capture agent, third capture agent, and fourth capture agent of the present invention.
[0051] The color-developing surface is the surface of the chromatography paper 29 on which the capture agent is disposed. The chromatography paper 29 has four color-developing surfaces. Each of the four color-developing surfaces corresponds to one of the four capture agents. The color-developing surface develops color (colors) when the amplified nucleic acid is captured by the capture agent. In other words, when the color-developing surface develops color, the chromatography paper 29 develops color.
[0052] 4 is a schematic diagram showing the state in which the amplifying members 50-53 are inserted into the tubes 25-28, and shows that the amplifying members 50-53 are disposed in the through holes of the tubes 25-28.
[0053] The tubes 25-28 have substantially the same shape and function, and the following description will be given of the shapes and functions of the tubes 25-28 using the tube 25 as an example.
[0054] The tube 25 is a tubular body. The tube 25 has a through hole. The tube 25 has a first opening 251 and a second opening 252. The first opening 251 is an opening arranged on the sample receiver 22 side. In other words, the tube 25 is connected to the sample receiver 22. The second opening 252 is an opening arranged on the chromatography paper 29 side.
[0055] The amplification members 50-53 have substantially the same shape and the same function (although the immobilized reagents are different). Therefore, the following description will be given of the shapes and functions of the amplification members 50-53 using the amplification member 50 as an example.
[0056] The amplification member 50 is a member on which a reagent is immobilized. The reagent immobilized on the amplification member 50 is a reagent for generating amplified nucleic acid from target nucleic acid. The reagent immobilized on the amplification member 50 is in a dry state. A reagent in a dry state can be stored at room temperature. Therefore, the present device 1 can be stored at room temperature. The amplification member 50 includes a carrier that supports the reagent. The carrier is an aggregate of a water-absorbent material such as glass fiber.
[0057] The amplifying member 50 is a wire. The amplifying member 50 is inserted into the through-hole of the tube 25. That is, the amplifying member 50 is disposed in the tube 25. The amplifying member 50 has one end 501 and the other end 502. The one end 501 is an end of the amplifying member 50. The one end 501 is disposed on the first opening 251 side. The one end 501 is exposed to the outside of the tube 25 from the first opening 251. The other end 502 is an end of the amplifying member 50. The other end 502 is disposed on the second opening 252 side. The other end 502 is exposed to the outside of the tube 25 from the second opening 252.
[0058] As described above, the amplifying members 50-53, which are wire bodies, are arranged in the tubes 25-28. The amplifying members 50-53 arranged in the tubes 25-28 are examples of the first wire body, second wire body, third wire body, and fourth wire body of the present invention.
[0059] 5 is a schematic diagram showing the state before the heater 30 is attached to the device 1. This figure shows that the heater 30 is attached to the device 1.
[0060] The heater 30 is a device for heating an object, and is an example of the heating means of the present invention.
[0061] The heater 30 includes an upper heater 31, a lower heater 32, and a power connector 33. The upper heater 31 is inserted into the upper heater insertion hole 11. The lower heater 32 is inserted into the lower heater insertion hole 21. The power connector 33 is a terminal connected to a power source 40 (see FIG. 6). The power connector 33 is a USB connector.
[0062] 6 is a schematic diagram showing the state after the heater 30 is attached to the device 1. The figure shows that the heater 30 is attached to the device 1. The figure also shows that the power connector 33 is connected to the power source 40.
[0063] The power supply 40 is a power source that supplies power to the heater 30. The power supply 40 is a USB power supply.
[0064] ●Operation of this device (1) The following explanation is an example when a subject is infected with one of four specific pathogens, that is, when the saliva collected from the subject contains nucleic acid derived from one specific pathogen.
[0065] First, the cap 12 is removed from the sample introduction hole 17 .
[0066] Next, the saliva is placed in the sample receiver 22 through the sample introduction hole 17. The saliva is collected in advance by the user and stored in a predetermined container. The user places the saliva stored in the container in the sample receiver 22 using a predetermined method (e.g., pipetting).
[0067] Next, the cap 12 is attached to the sample introduction hole 17 .
[0068] Next, the heater 30 is attached to the device 1. That is, the upper heater 31 is inserted into the upper heater insertion hole 11. The lower heater 32 is inserted into the lower heater insertion hole 21. The tube attachment member 24 is disposed between the upper heater 31 and the lower heater 32.
[0069] Next, the saliva placed in the sample receiver 22 penetrates into the ends 501-531 of the amplifying members 50-53 exposed to the outside of the tubes 25-28 and their surrounding areas. The saliva that penetrates into the ends 501-531 of the amplifying members 50-53 and their surrounding areas is absorbed into the tubes 25-28. The tubes 25-28 attached to the tube attachment member 24 are heated by the heater 30. That is, the saliva absorbed into the tubes 25-28 is heated by the heater 30.
[0070] Next, the saliva absorbed into the tube 25-28 moves from one end 501-531 toward the other end 502-532. The movement of the saliva inside the tube 25-28 is due to capillary action of the tube 25-28. The saliva moving inside the tube 25-28 mixes with the reagent immobilized on the amplification member 50-53.
[0071] The saliva moving through the tubes 25-28 is heated by the heater 30. The heater 30 heats the saliva in the tubes 25-28 to a temperature (e.g., 65°C) suitable for amplifying the target nucleic acid contained in the saliva. Here, for example, the heating operation of the heater 30 starts before the saliva is placed in the sample receiver 22. The target nucleic acid contained in the heated saliva is amplified. As a result, amplified nucleic acid is produced.
[0072] In this way, the saliva moving through the tubes 25-28 slowly diffuses into the amplification members 50-53, which are carriers that hold the reagent. The saliva that diffuses into the amplification members 50-53 mixes with the reagent immobilized on the amplification members 50-53. As a result, the target nucleic acid contained in the saliva is amplified. In other words, amplification of the target nucleic acid in this device 1 does not require stirring or centrifugation of the reagent.
[0073] Next, the user presses the first button 13. The developing liquid tank 18 housed in the first button 13 moves downward together with the first button 13 toward the needle 23. The developing liquid tank 18 comes into contact with the needle 23. Upon contact with the needle 23, the developing liquid tank 18 bursts. When the developing liquid tank 18 bursts, the developing liquid stored in the developing liquid tank 18 is released from the developing liquid tank 18. The released developing liquid is placed in the sample receiver 22.
[0074] The timing at which the user presses the first button 13 is related to the amplification time of the target nucleic acid placed in the tubes 25-28. The amplification time of the target nucleic acid is the time required for the target nucleic acid to amplify and produce a detectable amplified nucleic acid. In other words, if the amplification time of the target nucleic acid is assumed to be 15 minutes, the user presses the first button 13 15 minutes after placing the saliva in the sample receiver 22.
[0075] Next, the developing solution placed in the sample receiver 22 permeates the ends 501-531 of the amplifying members 50-53 exposed to the outside of the tube 25-28 from the first openings 251-281 and the surrounding area. The developing solution that has permeated the ends 501-531 of the amplifying members 50-53 and the surrounding area is absorbed into the tube 25-28.
[0076] Next, the developer liquid absorbed into the tube 25-28 moves from one end 501-531 toward the other end 502-532. The movement of the developer liquid in the tube 25-28 is due to the capillary phenomenon of the tube 25-28. The developer liquid moving in the tube 25-28 is mixed with the amplification liquid in the tube 25-28. As a result, a detection liquid is produced.
[0077] Next, the user presses the second button 15. The water absorbent body 19 held by the second button 15 moves downward together with the second button 15. As a result, the water absorbent body 19 is disposed between the tubes 25-28 and the chromatography paper 29.
[0078] The water absorbent body 19 disposed between the tubes 25-28 and the chromatography paper 29 remains disposed therebetween even after the second button 15 is released from the depressed state.
[0079] Here, the timing at which the user presses the second button 15 (hereinafter referred to as the "second timing") is related to the timing at which the user presses the first button 13 (hereinafter referred to as the "first timing") The second timing is the time a predetermined time (e.g., three minutes) has elapsed since the first timing.
[0080] The first contact portion 191 of the water absorbent body 19 disposed between the tube 25-28 and the chromatography paper 29 contacts the amplifying member 50-53. The first contact portion 191 contacts the whole or part of the portion of the amplifying member 50-53 that is exposed through the second opening 252-282.
[0081] The second contact portion 192 of the water absorbent body 19, which is disposed between the tubes 25-28 and the chromatography paper 29, contacts the chromatography paper 29. The second contact portion 192 contacts one end of the chromatography paper 29 on the second contact portion 192 side and a portion in the vicinity thereof.
[0082] Next, the water absorber 19 absorbs the detection liquid in the amplifying members 50-53 from the first contact portion 191 that contacts the amplifying members 50-53.
[0083] Next, the detection liquid absorbed by the absorbent body 19 is supplied to the chromatography paper 29 from the second contact portion 192 that is in contact with the chromatography paper 29 .
[0084] Next, the detection solution supplied to the chromatography paper 29 moves from the upstream end to the downstream end on the chromatography paper 29. The detection solution is mixed with the color developer arranged on the upstream end side of the chromatography paper 29.
[0085] Next, the amplified nucleic acid in the detection solution mixed with the color developer binds to the color developer.
[0086] The amplified nucleic acid bound to the color developer then moves toward the downstream end on the chromatography paper 29. The amplified nucleic acid moving along the chromatography paper 29 is mixed with a capture agent disposed on the color developer surface of the chromatography paper 29.
[0087] The amplified nucleic acid then binds to the capture agent, and the amplified nucleic acid has a site that binds to the color developer and a site that binds to the capture agent, the site that binds to the color developer being different from the site that binds to the capture agent.
[0088] Next, the amplified nucleic acid bound to the capture agent is immobilized on the color-developing surface (chromatography paper 29) via the capture agent.
[0089] The color-developing surface then develops color due to the color-developing agent that binds to the amplified nucleic acid immobilized on the color-developing surface.
[0090] The colored surface constitutes the chromatography paper 29. The chromatography paper 29 having the colored surface can be seen through the second window 16.
[0091] The user confirms that one of the four colored surfaces of the chromatography paper 29 has developed a color. In other words, the user determines that the subject is infected with one of the four pathogens to be detected by the device 1, the one that corresponds to the colored surface.
[0092] Summary (1) As explained above, the device 1 includes the sample receiver 22, the tubes 25-28, the chromatography paper 29, and the amplification members 50-53. The amplification members 50-53 are disposed in the tubes 25-28. The saliva disposed in the sample receiver 22 is absorbed into the tubes 25-28. The saliva absorbed into the tubes 25-28 is mixed with the reagent immobilized on the amplification members 50-53 disposed in the tubes 25-28. In other words, the saliva is disposed in the sample receiver 22. As a result, the saliva is mixed with the reagent. Here, the saliva disposed in the sample receiver 22 is absorbed into the tubes 25-28 by capillary action caused by the tubes 25-28. In other words, the saliva disposed in the sample receiver 22 is mixed with the sample without any user operation. In other words, the device 1 can mix saliva with the sample without relying on the user's skill.
[0093] As described above, the device 1 includes the second button 15 and the water absorbent body 19. When the second button 15 is pressed, the water absorbent body 19 is disposed between the tube 25-28 and the chromatography paper 29. The water absorbent body 19, disposed between the tube 25-28 and the chromatography paper 29, absorbs the detection liquid from the tube 25-28. The water absorbent body 19, having absorbed the detection liquid, supplies the detection liquid to the chromatography paper 29. In other words, when the second button 15 is pressed, the detection liquid is supplied from the tube 25-28 to the chromatography paper 29. In other words, the detection liquid is supplied to the chromatography paper 29 simply by the user pressing the second button 15. In other words, the device 1 can supply the detection liquid to the chromatography paper 29 without relying on the user's skill.
[0094] Furthermore, as described above, the device 1 includes a housing (cover 10 and base 20), a cap 12, and a sample introduction hole 17. The housing accommodates the absorbent body 19, the sample receiver 22, the tubes 25-28, the chromatography paper 29, and the amplification members 50-53. The cap 12 seals the sample introduction hole 17. The sample introduction hole 17 is a hole through which a sample to be placed in the sample receiver 22 is introduced. The sample introduction hole 17 is placed in the cover 10. The cap 12 is removed from the sample introduction hole 17 when saliva is placed in the sample receiver 22. The cap 12 is attached to the sample introduction hole 17 when saliva is placed in the sample receiver 22 via the sample introduction hole 17. When the sample introduction hole 17 is not sealed (attached) by the cap 12, the interior of the housing communicates with the outside of the housing only via the sample introduction hole 17. That is, the inside of the housing communicates with the outside only when saliva is introduced through the sample introduction hole 17. In other words, the inside of the device 1 is sealed except when saliva is being introduced (when the cap 12 is removed from the sample introduction hole 17).
[0095] Furthermore, as described above, the device 1 includes the second window 16. The second window 16 allows the user to view the chromatography paper 29 from outside the housing. That is, the chromatography paper 29 is observed by the user through the second window 16. That is, the user can observe the presence or absence of coloration of the chromatography paper 29 through the second window 16. Based on the presence or absence of coloration of the chromatography paper 29, the user can determine whether or not nucleic acid derived from a specific pathogen is contained in the saliva collected from the subject.
[0096] Furthermore, as described above, the device 1 includes the first button 13, the developer tank 18, and the needle 23. The first button 13, together with the needle 23, constitutes a release means. The first button 13 moves the developer tank 18 toward the needle 23. The developer tank 18 stores a developer solution that supplies the amplified nucleic acid toward the chromatography paper 29. When the first button 13 is pressed and the developer tank 18 moves, the needle 23 breaks a portion of the developer tank 18. When the needle 23 breaks a portion of the developer tank 18, the developer solution is released from the developer tank 18. In other words, when the first button 13 is pressed by the user, the developer solution is released from the developer tank 18. The developer solution released from the developer tank 18 is supplied to the tubes 25-28. The developing liquid supplied to the tubes 25-28 is mixed with the amplification liquid inside the tubes 25-28. That is, the developing liquid is mixed with the amplification liquid simply by the user pressing the first button 13. In other words, the device 1 can mix the developing liquid and amplification liquid without relying on the skill of the user.
[0097] Furthermore, as explained above, the reagent includes a first reagent that amplifies nucleic acid and a second reagent that amplifies nucleic acid. The wire includes a first wire disposed inside the tubular body and a second wire disposed inside the tubular body. The first reagent is immobilized on the first wire. The second reagent is immobilized on the second wire. In other words, the first wire and the second wire are disposed inside the tubular body. As a result, the device 1 can simultaneously amplify target nucleic acids contained in saliva using multiple reagents.
[0098] Furthermore, as explained above, the target nucleic acid includes a first nucleic acid and a second nucleic acid. The reagents include a first reagent for amplifying the nucleic acid and a second reagent for amplifying the nucleic acid. The first reagent amplifies the first nucleic acid. The second reagent amplifies the second nucleic acid. In other words, the device 1 can simultaneously amplify nucleic acids derived from multiple specific pathogens. As a result, the device 1 can simultaneously detect the presence or absence of infection with any of multiple specific pathogens.
[0099] Furthermore, as explained above, the device 1 includes the second button 15 and the water absorbent body 19. The water absorbent body 19 includes a first contact portion 191 and a second contact portion 192. The first contact portion 191 contacts the amplifying members 50-53. The second contact portion 192 contacts the chromatography paper 29. When the second button 15 is pressed, the water absorbent body 19 is disposed between the chromatography paper 29 and the amplifying members 50-53. The detection liquid produced in the amplifying members 50-53 is supplied from the first contact portion 191 to the second contact portion 192. The detection liquid is supplied from the second contact portion 192 to the chromatography paper 29. In other words, the detection liquid absorbed by the water absorbent body 19 is supplied to the chromatography paper 29 when the second button 15 is pressed. In other words, the device 1 can supply the detection liquid to the chromatography paper 29 without depending on the skill of the user.
[0100] In the above description, the number of target nucleic acids detected by the present device 1 is four. However, the number of target nucleic acids detected by the present device is not limited to this. That is, for example, the number of target nucleic acids detected by the present device may be one or more (excluding four).
[0101] Furthermore, in the above description, the number of reagents provided in the device 1 corresponds to the number of target nucleic acids detected by the device 1. However, the number of reagents provided in the device does not necessarily correspond to the number of target nucleic acids detected by the device. That is, for example, the device may be provided with multiple reagents corresponding to one type of target nucleic acid detected by the device. In other words, the number of reagents provided in the device is set appropriately depending on the number of target nucleic acids detected by the device.
[0102] Furthermore, in the above description, the number of wires included in the device 1 is equal to the number of reagents included in the device 1. However, the number of wires included in the device does not necessarily equal the number of reagents included in the device. That is, for example, the device may include one wire to which multiple reagents are immobilized.
[0103] ●Second embodiment of the present device and the present method● Another embodiment (second embodiment) of the present device and the present method described below will be described focusing on the differences from the previously described embodiment of the present method (first embodiment).
[0104] The second embodiment differs from the first embodiment in that the number of first supply paths is one, in that the second embodiment has one first supply path. The second embodiment differs from the first embodiment in that the entire first supply path is housed in the housing, in that a portion of the first supply path is exposed to the outside of the housing. The second embodiment differs from the first embodiment in that the developer tank is disposed in the cover, in that the developer tank is disposed in the base.
[0105] The following explanation is an example in which the presence or absence of infection with one specific type of pathogen is determined from one sample (saliva). The saliva may contain one type of target nucleic acid corresponding to one specific type of pathogen. The device includes one type of reagent. The reagent corresponds to the one type of target nucleic acid. The reagent generates an amplified nucleic acid from the corresponding target nucleic acid. The reagent is placed in a tube that is a supply path for the saliva. The device includes one tube. One type of reagent is placed in one tube.
[0106] Configuration of the Present Device (2) FIG. 7 is an exploded perspective view of the present device showing another embodiment of the present device.
[0107] The device 1a includes a cover 10a and a base 20a.
[0108] The cover 10a includes a cap 12a, a first button 13a, a second button 15a, a second window (not shown), a sample introduction hole 17a, a water absorbent body 19a, and a needle 23a.
[0109] The base 20a includes a developing solution tank 18a, a sample receiver 22a, a tube 25a, chromatography paper 29a, and an amplifying member 50a.
[0110] The cover 10a, cap 12a, first button 13a, second button 15a, second window (not shown), sample introduction hole 17a, developing solution tank 18a, absorbent body 19a, base 20a, sample receiver 22a, needle 23a, tube 25a, chromatography paper 29a, and amplification member 50a correspond to the cover 10, cap 12, first button 13, second button 15, second window 16, sample introduction hole 17, developing solution tank 18, absorbent body 19, base 20, sample receiver 22, needle 23, tube 25, chromatography paper 29, and amplification member 50, respectively, in the first embodiment.
[0111] Unlike the cover 10, the cover 10a does not include a developing liquid tank 18a. Unlike the cover 10, the cover 10a includes a needle 23a.
[0112] Unlike the first button 13, the first button 13a does not include a developer tank 18a. Unlike the first button 13, the first button 13a includes a needle 23a. When the user presses the first button 13a, the first button 13a moves the needle 23a downward. The first button 13a is an example of a movement operation member according to the present invention.
[0113] The base 20a is different from the base 20 in that it includes a developer tank 18a. The base 20a is different from the base 20 in that it does not include a needle 23a.
[0114] Unlike tubes 25-28, a portion of tube 25a is exposed to the outside of the housing (cover 10a and base 20a). Both ends of tube 25a and their neighboring portions are housed in the housing. The remaining portion of tube 25a is exposed to the outside of the housing so that it can be heated by a heating means.
[0115] Unlike the chromatography paper 29, the chromatography paper 29a has one color-developing surface.
[0116] Operation of this device (2) The following explanation is an example when the subject is infected with a specific type of pathogen, that is, when the saliva collected from the subject contains nucleic acid derived from a specific type of pathogen.
[0117] First, the cap 12a is removed from the sample introduction hole 17a.
[0118] Next, the saliva is placed in the sample receiver 22a through the sample introduction hole 17a.
[0119] Next, the cap 12a is attached to the sample introduction hole 17a.
[0120] Next, the heater 30a is attached to the device 1a. That is, the upper heater 31a is disposed above the tube 25a, and the lower heater 32a is disposed below the tube 25a. The tube 25a is heated by the heater 30a.
[0121] Next, the saliva placed in the sample receiver 22a permeates the end 501a of the amplifying member 50a exposed to the outside of the tube 25a and the surrounding area thereof. The saliva that has permeated the end 501a of the amplifying member 50a and the surrounding area thereof is absorbed into the tube 25a.
[0122] Next, the saliva absorbed into tube 25a moves from one end 501a toward the other end 502a. The movement of saliva inside tube 25a is due to capillary action of tube 25a. The saliva moving inside tube 25a is mixed with the reagent immobilized on amplification member 50a.
[0123] The saliva moving through the tube 25a is heated by the upper heater 31a and the lower heater 32a (hereinafter collectively referred to as the "upper and lower heaters"). The upper and lower heaters are devices for heating an object. The upper and lower heaters are examples of heating means in the present invention. The upper and lower heaters operate to heat the saliva in the tube 25a to a temperature (e.g., 65°C) suitable for amplifying the target nucleic acid contained in the saliva. The target nucleic acid contained in the heated saliva is amplified. As a result, amplified nucleic acid is produced.
[0124] Next, the first button 13a is pressed by the user. The needle 23a attached to the first button 13a moves downward together with the first button 13a toward the developing liquid tank 18a. The needle 23a comes into contact with the developing liquid tank 18a. The developing liquid tank 18a that has come into contact with the needle 23a bursts. When the developing liquid tank 18a bursts, the developing liquid stored in the developing liquid tank 18a is released from the developing liquid tank 18a. The released developing liquid is placed in the sample receiver 22a.
[0125] Next, the developing solution placed in the sample receiver 22a permeates the end 501a of the amplifying member 50a exposed to the outside of the tube 25a and the surrounding area thereof. The developing solution that has permeated the end 501a of the amplifying member 50a and the surrounding area thereof is absorbed into the tube 25a.
[0126] Next, the developer liquid absorbed into the tube 25a moves from one end 501a toward the other end 502a. The movement of the developer liquid in the tube 25a is due to capillary action of the tube 25a. The developer liquid moving in the tube 25a mixes with the amplification liquid in the tube 25a. As a result, a detection liquid is produced.
[0127] Next, the user presses the second button 15a, and the water absorbent body 19a held by the second button 15a moves downward together with the second button 15a and is positioned between the tube 25a and the chromatography paper 29a.
[0128] The water absorbent body 19a disposed between the tube 25a and the chromatography paper 29a remains disposed therebetween even after the pressing operation of the second button 15a is released.
[0129] The first contact portion 191a of the water absorbent body 19a, which is disposed between the tube 25a and the chromatography paper 29a, contacts the amplifying member 50a. The first contact portion 191a contacts the entire or part of the portion of the amplifying member 50a that is exposed through the second opening (not shown).
[0130] The second contact portion 192a of the water absorbent body 19a, which is disposed between the tube 25a and the chromatography paper 29a, contacts the chromatography paper 29a. The second contact portion 192a contacts one end of the chromatography paper 29a on the second contact portion 192a side and a portion in the vicinity thereof.
[0131] Next, the water absorber 19a absorbs the detection liquid in the amplifying member 50a from the first contact portion 191a that is in contact with the amplifying member 50a.
[0132] Next, the detection liquid absorbed by the absorbent body 19a is supplied to the chromatography paper 29a from the second contact portion 192a that is in contact with the chromatography paper 29a.
[0133] The detection solution supplied to the chromatography paper 29a then moves from the upstream end to the downstream end on the chromatography paper 29a, where it is mixed with the color developer located on the upstream end of the chromatography paper 29a.
[0134] Next, the amplified nucleic acid in the detection solution mixed with the color developer is bound to the color developer.
[0135] The amplified nucleic acid bound to the color developer then moves on the chromatography paper 29a toward the downstream end, where it mixes with the capture agent disposed on the color developer surface of the chromatography paper 29a.
[0136] The amplified nucleic acid mixed with the capture agent then binds to the capture agent.
[0137] Next, the amplified nucleic acid bound to the capture agent is immobilized on the color-developing surface (chromatography paper 29a) via the capture agent.
[0138] The color-developing surface then develops color due to the color-developing agent that binds to the amplified nucleic acid immobilized on the color-developing surface.
[0139] The colored surface constitutes the chromatography paper 29a. The chromatography paper 29a having the colored surface can be viewed through a second window (not shown) disposed in the cover 10a.
[0140] The user confirms that the colored surface of the chromatography paper 29a has developed a color, and determines that the subject is infected with one of the pathogens that are the detection targets of the device 1a.
[0141] Summary (2) As explained above, the device 1a includes a housing (cover 10a and base 20a) and a tube 25a. A portion of the tube 25a is housed in the housing. The other portion of the tube 25a is exposed to the outside of the housing so that it can be heated by a heating means. Because the other portion of the tube 25a is exposed to the outside of the housing, the options for heating means for the tube 25a increase.
[0142] Furthermore, as explained above, since the other part of the tube 25a is exposed to the outside of the housing, it is easier to reduce the size of the device 1a than to reduce the size of the device 1 in which the tube 25a is housed in the housing.
[0143] In the above description, the number of target nucleic acids detected by the present device 1a is 1. However, the number of target nucleic acids detected by the present device is not limited to this. That is, for example, the number of target nucleic acids detected by the present device may be 2 or more.
[0144] Furthermore, in the above description, the number of reagents included in the device 1a is the same as the number of target nucleic acids detected by the device 1a. However, the number of reagents included in the device is not limited to this. That is, for example, the device may be provided with multiple reagents corresponding to one type of target nucleic acid detected by the device. In other words, the number of reagents included in the device is set appropriately depending on the number of target nucleic acids detected by the device.
[0145] Furthermore, in the above description, the number of wires included in the device 1a is the same as the number of reagents included in the device 1a. However, the number of wires included in the device is not limited to this. For example, the device may include one wire to which multiple reagents are immobilized.
[0146] ●Other embodiments● The other embodiments (third embodiment to fifth embodiment) of the present device and method described below will be explained focusing on the differences from the previously described embodiments (first and second embodiments) of the present device and method.
[0147] In the following description, when there is no particular distinction between the device 1 and the device 1a, the device 1 and the device 1a will each be referred to as the device 1x.
[0148] In the following description, when the second button 15 and the second button 15a are not particularly distinguished from each other, the second button 15 and the second button 15a will be referred to as the second button 15x.
[0149] Furthermore, in the following description, when the absorbent body 19 and the absorbent body 19a are not particularly distinguished from each other, the absorbent body 19 and the absorbent body 19a will be referred to as the absorbent body 19x.
[0150] Furthermore, in the following description, when the base 20 and the base 20a are not particularly distinguished from each other, the base 20 and the base 20a will each be referred to as a base 20x.
[0151] Furthermore, in the following description, when the sample receiver 22 and the sample receiver 22a are not particularly distinguished from each other, the sample receiver 22 and the sample receiver 22a will be referred to as the sample receiver 22x.
[0152] Furthermore, in the following description, when tubes 25-28 and tube 25a are not particularly distinguished from each other, tubes 25-28 and tube 25a will be referred to as tube 25x.
[0153] Furthermore, in the following description, when the chromatography paper 29 and the chromatography paper 29a are not particularly distinguished from each other, the chromatography paper 29 and the chromatography paper 29a will each be referred to as the chromatography paper 29x.
[0154] Furthermore, in the following description, when the amplifying members 50-53 and the amplifying member 50a are not particularly distinguished from each other, the amplifying members 50-53 and the amplifying member 50a will each be referred to as an amplifying member 50x.
[0155] Furthermore, in the following description, "downstream direction" refers to the direction in which amplified nucleic acid is fed to the chromatography paper. "Upstream direction" refers to the direction opposite to the downstream direction. "Feed direction" refers collectively to the upstream and downstream directions.
[0156] Furthermore, in the following description, the tube 25x is connected to the sample receiver 22x.
[0157] Furthermore, in the following description, the amplifying member 50x is disposed in the tube 25x.
[0158] Differences between the first and second embodiments and the third to fifth embodiments
[0159] First and Second Embodiments Fig. 8 is a schematic diagram showing the second button 15x being operated. This figure shows that the water absorbent body 19x is held by the second button 15x. In the figure, the white arrow indicates the direction of movement of the second button 15x when the second button 15x is operated (when the user presses the second button 15x). Fig. 9 is a schematic diagram showing the state in which the amplifying member 50x is connected to the chromatography paper 29x.
[0160] In the first and second embodiments, the device 1x includes a second button 15x, a water absorbent body 19x, a base 20x, a tube 25x, chromatography paper 29x, and an amplifying member 50x. The second button 15x is disposed above the amplifying member 50x.
[0161] When the second button 15x is operated, the water absorbent body 19x is disposed between the tube 25x and the chromatography paper 29x.
[0162] The water absorbent body 19x, which is disposed between the tube 25x and the chromatography paper 29x, contacts the amplifying member 50x and the chromatography paper 29x. That is, the water absorbent body 19x connects the amplifying member 50x and the chromatography paper 29x. In other words, when the second button 15x is operated, the amplifying member 50x is connected to the chromatography paper 29x via the water absorbent body 19x. The water absorbent body 19x in contact with the amplifying member 50x absorbs the detection liquid contained in the amplifying member 50x from the amplifying member 50x. The detection liquid absorbed by the water absorbent body 19x from the amplifying member 50x is supplied from the water absorbent body 19x to the chromatography paper 29x.
[0163] In this way, the amplified nucleic acid is supplied to the chromatography paper 29x when the second button 15x is operated. In other words, the second button 15x causes the amplified nucleic acid to be supplied to the chromatography paper 29x.
[0164] Embodiment 3-5 Embodiment 3-5 differs from the first and second embodiments in that the second supply channel is attached to one end of the upstream side of the test strip, in that the second supply channel is held by the supply operation member.
[0165] The third and fourth embodiments differ from the first and second embodiments in that the apparatus includes a mounting table. The mounting table will be described in detail later.
[0166] The third embodiment differs from the first and second embodiments in that the supply operation member positions the second supply channel between the first supply channel and the test strip, in that the supply operation member presses down the second supply channel.
[0167] The fourth embodiment differs from the first and second embodiments in that the device includes a connecting member, the details of which will be described later.
[0168] The fourth embodiment differs from the first and second embodiments in that the supply operation member connects the amplifying member to the second supply path, in that the supply operation member positions the second supply path between the first supply path and the test piece.
[0169] The fifth embodiment differs from the first and second embodiments in that the supply operation member is attached to the other end of the downstream side of the test strip, in that the supply operation member is attached to (disposed on) the housing.
[0170] The fifth embodiment differs from the first and second embodiments in that the supply operation member positions the second supply passage between the first supply passage and the test piece, in that the supply operation member presses the second supply passage.
[0171] In the following description of the third to fifth embodiments, for convenience of explanation, the same names as in the first and second embodiments are used for the members corresponding to those in the first and second embodiments.
[0172] In addition, in the following description of the third to fifth embodiments, for convenience of explanation, the same components as those in the first and second embodiments and components having common functions are given the same reference numerals as those in the first and second embodiments.
[0173] Furthermore, in the following description of the third to fifth embodiments, the detection liquid is generated in the tube 25x (amplifying member 50x). The detection liquid is disposed in the tube 25x (amplifying member 50x).
[0174] Third Embodiment of the Present Apparatus and Method A third embodiment of the present apparatus and method is described below.
[0175] Fig. 10 is a schematic diagram showing another embodiment of the device, illustrating the state in which the second button 15b is operated. In the figure, the white arrow indicates the direction of movement of the second button 15b when the second button 15b is operated (i.e., pressed by the user). Fig. 11 is a schematic diagram showing the state in which the amplifying member 50x is connected to the chromatography paper 29b.
[0176] The second button 15b is a button for pressing down the water absorbent body 19b. The second button 15b is arranged above the amplifying member 50x. The second button 15b is arranged above the water absorbent body 19b. The second button 15b is an example of a supply operation member according to the present invention.
[0177] The water absorbent 19b supplies the detection solution generated in the tube 25x (amplification member 50x) to the chromatography paper 29b. The water absorbent 19b is attached to one end (not shown) on the upstream side of the chromatography paper 29b in the supply direction of the amplified nucleic acid. The water absorbent 19b is disposed between the amplification member 50x and the second button 15b in the vertical direction. The one end will be described in detail later.
[0178] Here, the second button 15b presses the water absorbent body 19b. That is, when the second button 15b is operated, the water absorbent body 19b is pressed by the second button 15b toward the amplifying member 50x. The water absorbent body 19b is an example of a second supply path according to the present invention.
[0179] The chromatography paper 29b is placed on the mounting base 34b. The chromatography paper 29b is disposed between the amplifying member 50x and the second button 15b in the vertical direction. The chromatography paper 29b has one end. The chromatography paper 29b is an example of a test strip according to the present invention. Details of the mounting base 34b will be described later.
[0180] The one end is the upstream end of the chromatography paper 29b. The one end is located upstream of the upstream end (not shown) of the mounting table 34b. In other words, the one end protrudes upstream from the upstream end of the mounting table 34b.
[0181] The mounting table 34b is a table on which the chromatography paper 29b is placed.
[0182] The following description is an example in which the second button 15b is operated to supply the amplified nucleic acid to the chromatography paper 29b.
[0183] First, the second button 15b is operated by the user.
[0184] Next, the second button 15b presses the water absorbent body 19b attached to one end of the chromatography paper 29b toward the amplifying member 50x.
[0185] Next, the water absorbent body 19b is connected to the amplifying member 50x. That is, the water absorbent body 19b connects the amplifying member 50x and the chromatography paper 29b. In other words, when the second button 15b is operated, the amplifying member 50x is connected to the chromatography paper 29b via the water absorbent body 19b.
[0186] Next, the detection solution produced by the amplification member 50x is supplied to the chromatography paper 29b via the water absorbent body 19b. In other words, the amplified nucleic acid is supplied to the chromatography paper 29b via the water absorbent body 19b.
[0187] In this way, the amplified nucleic acid is supplied to the chromatography paper 29b when the second button 15b is operated. In other words, the second button 15b causes the amplified nucleic acid to be supplied to the chromatography paper 29b.
[0188] Fourth Embodiment of the Present Apparatus and Method A fourth embodiment of the present apparatus and method is described below.
[0189] Fig. 12 is a schematic diagram showing yet another embodiment of the present device, illustrating the state in which the second button 15c is operated. In the figure, the white arrow indicates the direction of movement of the second button 15c when the second button 15c is operated (i.e., the user pulls up the second button 15c). Fig. 13 is a schematic diagram showing the state in which the amplifying member 50x is connected to the chromatography paper 29c.
[0190] The second button 15c is a button that connects the amplifying member 50x to the water absorber 19c. The second button 15c is arranged above the amplifying member 50x. The second button 15c is arranged above the water absorber 19c. The second button 15c is an example of a supply operation member according to the present invention.
[0191] The water absorbent body 19c supplies the detection solution generated in the tube 25x (amplification member 50x) to the chromatography paper 29c. The water absorbent body 19c is attached to one end (not shown) on the upstream side of the chromatography paper 29c in the supply direction of the amplified nucleic acid. The water absorbent body 19c is disposed between the amplification member 50x and the second button 15c in the vertical direction. The water absorbent body 19c is an example of a second supply path in the present invention. The one end will be described in detail later.
[0192] The chromatography paper 29c is placed on the mounting table 34c. The chromatography paper 29c is disposed between the amplifying member 50x and the second button 15c in the vertical direction. The chromatography paper 29c has one end. The chromatography paper 29c is an example of a test strip according to the present invention.
[0193] The one end is the upstream end of the chromatography paper 29c. The one end is located upstream of the upstream end (not shown) of the mounting table 34c. In other words, the one end protrudes upstream from the upstream end of the mounting table 34c.
[0194] The mounting table 34c is a table on which the chromatography paper 29c is placed.
[0195] The connecting member 35 is a member that connects the amplifying member 50x and the second button 15c. The connecting member 35 is thread-like.
[0196] Here, the second button 15c connects the amplifying member 50x to the water absorber 19c. That is, the amplifying member 50x connected to the connecting member 35 is connected to the water absorber 19c when the second button 15c is operated.
[0197] The following description is an example in which the second button 15c is operated to supply the amplified nucleic acid to the chromatography paper 29c.
[0198] First, the second button 15c is operated by the user.
[0199] Next, the amplifying member 50x connected to the connecting member 35 is connected to the water absorbent body 19c. That is, the water absorbent body 19c connects the amplifying member 50x to the chromatography paper 29c. In other words, when the second button 15c is operated, the amplifying member 50x is connected to the chromatography paper 29c via the water absorbent body 19c.
[0200] Next, the detection solution produced by the amplification member 50x is supplied to the chromatography paper 29c via the water absorbent body 19c. In other words, the amplified nucleic acid is supplied to the chromatography paper 29c via the water absorbent body 19c.
[0201] In this way, the amplified nucleic acid is supplied to the chromatography paper 29c when the second button 15c is operated. In other words, the second button 15c causes the amplified nucleic acid to be supplied to the chromatography paper 29c.
[0202] Fifth Embodiment of the Present Apparatus and Method A fifth embodiment of the present apparatus and method is described below.
[0203] Fig. 14 is a schematic diagram showing yet another embodiment of the present device, illustrating the state in which the second button 15d is being operated. In the figure, the white arrow indicates the direction of movement of the second button 15d when the second button 15d is operated (i.e., when the user presses the second button 15d). Fig. 15 is a schematic diagram showing the state in which the amplifying member 50x is connected to the chromatography paper 29d.
[0204] The second button 15d is a button that presses the water absorbent body 19d. The second button 15d is attached to the other end (not shown) on the downstream side of the chromatography paper 29d. That is, the second button 15d is disposed downstream of the chromatography paper 29d in the supply direction of the amplified nucleic acid. The second button 15d is an example of a supply operation member of the present invention. Details of the other end will be described later.
[0205] The water absorbent 19d supplies the detection solution generated in the tube 25x (amplification member 50x) to the chromatography paper 29d. The water absorbent 19d is attached to one end (not shown) on the upstream side of the chromatography paper 29d in the supply direction of the amplified nucleic acid. The water absorbent 19d is disposed between the amplification member 50x and the second button 15d in the supply direction of the amplified nucleic acid. Details of the one end will be described later.
[0206] Here, the second button 15d presses the water absorbent body 19d. That is, when the second button 15d is operated, the water absorbent body 19d is pressed by the second button 15d toward the amplifying member 50x. As a result, the water absorbent body 19d is connected to the amplifying member 50x. The water absorbent body 19d is an example of a second supply path in the present invention.
[0207] The chromatography paper 29d is disposed between the amplification member 50x and the second button 15d in the supply direction of the amplified nucleic acid. The chromatography paper 29d has one end and the other end. The chromatography paper 29d is an example of a test strip according to the present invention.
[0208] One end is the upstream end of the chromatography paper 29d.
[0209] The other end is the downstream end of the chromatography paper 29d.
[0210] The following description is an example in which the second button 15d is operated, resulting in the amplified nucleic acid being supplied to the chromatography paper 29d.
[0211] First, the second button 15d is operated by the user.
[0212] Next, the second button 15d presses the water absorbent body 19d attached to one end of the chromatography paper 29d.
[0213] Next, the water absorbent body 19d is connected to the amplifying member 50x. That is, the water absorbent body 19d connects the amplifying member 50x and the chromatography paper 29d. In other words, when the second button 15d is operated, the amplifying member 50x is connected to the chromatography paper 29d via the water absorbent body 19d.
[0214] Next, the detection solution produced by the amplification member 50x is supplied to the chromatography paper 29d via the water absorbent body 19d. In other words, the amplified nucleic acid is supplied to the chromatography paper 29d via the water absorbent body 19d.
[0215] In this way, the amplified nucleic acid is supplied to the chromatography paper 29d when the second button 15d is operated. In other words, the second button 15d causes the amplified nucleic acid to be supplied to the chromatography paper 29d.
[0216] ●Configuration of the heating device● This heating device heats the present device. This device is a detection device according to the first to fifth embodiments. That is, the present device, which is heated by this heating device, detects amplified nucleic acid generated from target nucleic acid contained in a sample.
[0217] The following description is an example in which the present heating device heats the present device 1a of the second embodiment.
[0218] In the following description, a sample (saliva) containing a target nucleic acid is introduced into the device 1a in advance. That is, the introduced saliva is absorbed into the tube 25a. That is, the saliva is placed inside the tube 25a.
[0219] 16 is a schematic diagram showing an embodiment of the present warming device, showing that the present device 1a is housed in the present warming device 60. In the figure, the white arrows indicate the direction of travel of the first button press portion 605 and the second button press portion 606.
[0220] The heating device 60 is a device that heats the device 1a and includes a heating housing 601, a heating unit 602, a heating start button 603, a motor 604, a first button pressing unit 605, a second button pressing unit 606, and a control unit (not shown).
[0221] The heating housing 601 houses the device 1a. The heating housing 601 includes a first housing 6011, a second housing 6012, and a third housing 6013.
[0222] The first housing 6011 , together with the second housing 6012 and the third housing 6013 , constitutes the heating housing 601 .
[0223] The second housing 6012, together with the first housing 6011 and the third housing 6013, constitutes the heating housing 601. A first hole (not shown) through which the first button depression portion 605 is inserted is formed between the first housing 6011 and the second housing 6012.
[0224] The third housing 6013, together with the first housing 6011 and the second housing 6012, constitutes the heating housing 601. A second hole (not shown) through which the second button depression portion 606 is inserted is formed between the second housing 6012 and the third housing 6013.
[0225] The heating unit 602 heats the tube 25a.
[0226] Here, the saliva contains the target nucleic acid. The saliva is placed in the tube 25a. That is, the heating unit 602 heats the target nucleic acid.
[0227] The heating start button 603 is a button for starting heating of the device 1a, and is an example of a heating start member in the present invention.
[0228] The motor 604 is a power source that supplies rotational power. The motor 604 supplies (transmits) the rotational power to the first button pressing portion 605 and the second button pressing portion 606. The motor 604 includes a motor rotation shaft 6041. The transmission of the rotational power will be described later.
[0229] The motor rotation shaft 6041 rotates due to rotational power from the motor 604. The motor rotation shaft 6041 is disposed between the first button press portion 605 and the second button press portion 606. The motor rotation shaft 6041 includes a gear portion 6041g.
[0230] The gear portion 6041g is a gear including a plurality of teeth (not shown) and a plurality of grooves (not shown). The gear portion 6041g meshes with the gear portion 605g and the gear portion 606g. Details of the gear portion 605g and the gear portion 606g will be described later.
[0231] The first button depressing portion 605 is a member that depresses the first button 13a. The first button depressing portion 605 is disposed above the first hole. The first button depressing portion 605 includes a first depressing portion 6051 and a gear portion 605g.
[0232] The first depressing portion 6051 depresses the first button 13a. The first depressing portion 6051 is disposed below the gear portion 605g. The first depressing portion 6051 is connected to the gear portion 605g.
[0233] The gear portion 605g is a gear that is configured with a plurality of teeth and a plurality of grooves, and meshes with the gear portion 6041g.
[0234] The second button depressing portion 606 is a member that depresses the second button 15a. The second button depressing portion 606 is disposed above the second hole. The second button depressing portion 606 includes a second depressing portion 6061 and a gear portion 606g.
[0235] The second depressing portion 6061 depresses the second button 15a. The second depressing portion 6061 is disposed below the gear portion 606g. The second depressing portion 6061 is connected to the gear portion 606g.
[0236] The gear portion 606g is a gear that is configured with a plurality of teeth and a plurality of grooves, and meshes with the gear portion 6041g.
[0237] The control unit controls the operation of the heating unit 602 and the operation of the motor 604. The operation of the heating unit 602 includes starting and stopping the heating of the device 1a. The operation of the motor 604 includes starting and stopping the rotation of the motor rotating shaft 6041.
[0238] The control unit notifies that a predetermined time has elapsed since the heating start button 603 was pressed (completion of the operation).
[0239] The control unit may notify the user, for example, by displaying the completion of the operation on a display (not shown) of the heating device 60, outputting sound from a sound source output device (not shown) of the heating device 60, or turning on an indicator light (not shown) of the heating device 60.
[0240] Transmission of Rotational Power In the following description, the first button 13a is arranged in the first hole, and the second button 15a is arranged in the second hole.
[0241] 17 is a schematic diagram showing the rotation of the first button pressing portion 605, the second button pressing portion 606, and the motor rotating shaft 6041, as viewed from the motor 604 side. In the figure, the black circle indicates the axis (not shown) of the motor rotating shaft 6041. In the figure, the clockwise arrow indicates the rotation direction of the motor rotating shaft 6041. The counterclockwise arrow indicates the rotation direction of the first button pressing portion 605 and the second button pressing portion 606.
[0242] The motor rotation shaft 6041 rotates clockwise due to the rotational power from the motor 604. That is, the gear portion 6041g rotates clockwise.
[0243] Here, gear portion 6041g is disposed between gear portion 605g and gear portion 606g. Gear portion 6041g meshes with gear portion 605g and gear portion 606g. That is, when gear portion 6041g rotates clockwise, gear portion 605g and gear portion 606g rotate counterclockwise. In other words, the rotational power from motor 604 is transmitted to gear portion 605g and gear portion 606g. In other words, the rotational power from motor 604 is transmitted to first button pressing portion 605 and second button pressing portion 606 via motor rotation shaft 6041.
[0244] When the gear part 605g rotates counterclockwise, the first button depressing part 605 moves toward the first hole. As a result, the first depressing part 6051 depresses the first button 13a. When the gear part 606g rotates counterclockwise, the second button depressing part 606 moves toward the second hole. As a result, the second depressing part 6061 depresses the second button 15a.
[0245] Operation of the Heating Device The following description is an example of when the heating device 60 heats the device 1a and presses the buttons (first button 13a and second button 15a) of the device 1a.
[0246] FIG. 18 is a schematic diagram showing a state in which the first button 13a and the second button 15a are pressed by the first button pressing portion 605 and the second button pressing portion 606, respectively.
[0247] First, the device 1 a is housed in a heating housing 601 .
[0248] Next, when the heating start button 603 is operated, the control unit controls the operation of the heating unit 602. That is, when the heating start button 603 is operated, the heating unit 602 starts heating the present device 1a. That is, when the heating start button 603 is operated, heating of the target nucleic acid inside the present device 1a is started. In other words, the heating start button 603 starts heating of the target nucleic acid by the heating unit 602.
[0249] Next, when a predetermined time (e.g., 30 minutes) has elapsed since the start of heating of the device 1a, the control unit controls the operation of the heating unit 602. That is, when the predetermined time has elapsed since the start of heating of the device 1a, the heating unit 602 stops heating of the device 1a. In other words, when the heating start button 603 is operated, the heating unit 602 heats the target nucleic acid for a predetermined time.
[0250] Next, the control unit controls the operation of the motor 604. That is, rotation of the motor shaft 6041 is started. That is, the motor shaft 6041 rotates together with the first button pressing part 605 and the second button pressing part 606. As a result, the first button pressing part 605 moves toward the first hole. The second button pressing part 606 moves toward the second hole (see FIGS. 16 and 17 ).
[0251] Next, the control unit controls the operation of the motor 604 when a predetermined time (e.g., 3 seconds) has elapsed since the start of rotation of the motor rotating shaft 6041. That is, when the predetermined time has elapsed since the start of rotation of the motor rotating shaft 6041, the rotation of the motor rotating shaft 6041 is stopped. At this time, the first button 13a is pressed by the first press portion 6051. The second button 15a is pressed by the second press portion 6061 (see FIG. 18 ).
[0252] Here, the distance between the first button 13a and the first push-down portion 6051 is shorter than the distance between the second button 15a and the second push-down portion 6061. In other words, the first button 13a is pushed down by the warming device 60 before the second button 15a.
[0253] In the present invention, the distance between the first button and the first depression portion may be the same as the distance between the second button and the second depression portion.
[0254] Next, the control unit notifies that a predetermined time (for example, 35 minutes) has elapsed since the heating start button 603 was pressed.
[0255] Summary (3) As explained above, the present heating device 60 includes a heating housing 601, a heating unit 602, and a heating start button 603. The heating housing 601 houses the present device 1a. The heating start button 603 causes the heating unit 602 to heat the present device 1a housed in the heating housing 601. When the heating start button 603 is operated, the heating unit 602 heats the present device 1a housed in the heating housing 601 for a predetermined time. In other words, when the heating start button 603 is operated, the target nucleic acid inside the present device 1a is heated by the heating unit 602 for a predetermined time. That is, the target nucleic acid is heated for a predetermined time simply by the user operating the heating start button 603. In other words, the present heating device 60 can heat the target nucleic acid without relying on the user's skill.
[0256] As described above, the warming device 60 includes a motor 604, a first button presser 605, a second button presser 606, and a control unit. The motor 604 supplies (transmits) rotational power to the first button presser 605 and the second button presser 606. The first button presser 605 presses the first button 13a based on the rotational power from the motor 604. The second button presser 606 presses the second button 15a based on the rotational power from the motor 604. The control unit controls the operation of the heating unit 602 and the operation of the motor 604 at a predetermined timing. The operation of the heating unit 602 includes starting and stopping the heating of the device 1a. The operation of the motor 604 includes starting and stopping the rotation of the motor rotation shaft 6041. The predetermined timing may be, for example, when the heating start button 603 is operated, when a predetermined time (e.g., 30 minutes) has elapsed since the start of heating of the device 1a, or when a predetermined time (e.g., 3 seconds) has elapsed since the start of rotation of the motor rotating shaft 6041. That is, the control unit controls the operation of the heating unit 602 and the operation of the motor 604 simply by the user operating the heating start button 603. In other words, the heating device 60 can heat the device 1a and press the buttons (first button 13a and second button 15a) of the device 1a without relying on the user's skill.
[0257] Summary In the embodiments described above, the device 1, 1a is used to determine whether a subject (human) is infected with a specific pathogen. However, the device may be used for purposes other than determining whether a human is infected with a specific pathogen. That is, for example, the device may be used to determine whether an animal is infected with a specific pathogen. The device may also be used to identify the species of various living organisms. Furthermore, the device may be used to determine genetic abnormalities in humans or animals. Furthermore, the device may be used to detect single-nucleotide mutations in drug-resistant bacteria.
[0258] In the above-described embodiment, the target nucleic acid is a nucleic acid derived from a microorganism that may be contained in the saliva of a subject (human). However, the target nucleic acid in the present invention is not limited to a nucleic acid derived from a microorganism that may be contained in human saliva. That is, for example, the target nucleic acid in the present invention may be a nucleic acid derived from a microorganism that may be contained in an animal sample or a nucleic acid derived from a non-pathogenic microorganism.
[0259] Furthermore, in the above-described embodiments, the sample is saliva from a subject (human). However, the sample in the present invention is not limited to human saliva. For example, the sample in the present invention may be human sputum, blood, serum, plasma, otorrhea, urine, or nasopharyngeal swab.
[0260] Furthermore, in the above-described embodiments, the heating means is a heater (30, 30a) including an upper heater (31, 31a) and a lower heater (32, 32a). That is, the first supply channel is heated from above and below. However, in the present invention, the first supply channel may be heated, for example, only from above or only from below. Furthermore, the heating means in the present invention is not limited to a heater. That is, the heating means in the present invention may be appropriately selected from among means capable of heating the target nucleic acid to a temperature at which the target nucleic acid is amplified, and may be, for example, a means using a constant-temperature water bath or a means utilizing the heat generated by a chemical reaction.
[0261] Furthermore, in the above-described embodiment, the color former is disposed on the chromatography paper (29, 29a). However, the location of the color former in the present invention is not limited to the chromatography paper. For example, the color former in the present invention may be disposed in the developer or the second supply channel.
[0262] Furthermore, in the above-described embodiment, the first supply passage is a tube (25-28, 25a). However, the first supply passage in the present invention is not limited to a tube. That is, for example, the first supply passage in the present invention may be configured as a groove formed in the base.
[0263] Furthermore, in the above-described embodiments, the target nucleic acid amplification method is the LAMP method, which is an isothermal nucleic acid amplification method. However, the target nucleic acid amplification method of the present invention is not limited to the LAMP method. For example, the target nucleic acid amplification method of the present invention may be the SDA (Strand Displacement Amplification) method, the HDA (Helicase-Dependent Amplification) method, the RPA (Recombinase Polymerase Amplification) method, the RCA (Rolling Circle Amplification) method, or the NASBA (Nucleic Acid Sequence-Based Amplification) method.
[0264] Furthermore, in the above-described embodiments, the carrier is a fiber assembly. However, the carrier of the present invention is not limited to a fiber assembly. That is, for example, the carrier of the present invention may be a solid or polymer having a microstructure, or a solid or polymer that gels upon absorbing water.
[0265] Furthermore, in the embodiments described above, the releasing means includes a breaking member (needle 23, 23a). That is, the developer is released from the developer tank by the breaking member breaking a part of the developer tank (18, 18a). However, the releasing means of the present invention is not limited to a breaking member breaking a part of the developer tank. That is, for example, the releasing means of the present invention may be one in which the developer tank's developer outlet slides to release the developer, or one in which a membrane that increases the permeability of the developer when heated is disposed at the outlet.
[0266] Furthermore, in the above-described embodiment, the developing solution is a mixture of water, phosphate buffer solution, sodium chloride, a surfactant such as Tween 20, and bovine serum albumin. However, the developing solution of the present invention is not limited to this mixture. That is, for example, the developing solution of the present invention may be one appropriately selected from developing solutions used in chromatography.
[0267] Furthermore, in the above-described embodiments, the developer is stored in the developer tank (18, 18a). The developer is released (introduced) downstream from the developer tank by rupturing a portion of the developer tank with the needle (23, 23a). However, the means for releasing the developer downstream (means for introducing the developer into the device) in the present invention is not limited to rupturing the developer tank. That is, for example, the developer may be introduced into the device from a syringe (not shown). The syringe stores the developer. The syringe storing the developer is inserted into a sample introduction hole. The user presses a depression member (not shown) of the syringe inserted into the sample introduction hole, thereby introducing the developer from the sample introduction hole into the device.
[0268] The means for introducing the developing liquid stored in the syringe into the present device is not limited to a pressing operation by the user. For example, the developing liquid stored in the syringe may be introduced into the present device by the discharge pressure of a pump (not shown).
[0269] Features of the present device, method and warming device The features of the present device, method and warming device that have been described so far are summarized below.
[0270] ●Characteristics of the device The device is a detection device (e.g., device 1, 1a) that detects amplified nucleic acid generated from a target nucleic acid contained in a sample, and is characterized by comprising: a sample placement member (e.g., sample receiver 22, 22a) on which the sample is placed; a test strip (e.g., chromatography paper 29, 29a, 29b, 29c, 29d) used for detecting the amplified nucleic acid; an amplification member (e.g., amplification member 50-53, 50a) on which a reagent used to generate the amplified nucleic acid from the target nucleic acid is immobilized; and a supply path (e.g., water absorbent 19, 19a, 19b, 19c, 19d, tube 25-28, 25a) that supplies the amplified nucleic acid toward the test strip, and the amplification member is placed in the supply path.
[0271] The device may comprise a supply operation member (e.g., second button 15, 15a, 15b, 15c, 15d) for supplying the amplified nucleic acid to the test piece, and the amplified nucleic acid may be supplied to the test piece when the supply operation member is operated.
[0272] In this device, the amplifying member may be connected to the test piece when the supply operating member is operated.
[0273] In this device, the test piece may be disposed between the amplifying member and the supply operation member.
[0274] In the present device, the supply operation member may be disposed above the amplifying member.
[0275] In this device, the supply operation member may be disposed downstream of the test piece in the supply direction of the amplified nucleic acid.
[0276] In this device, the supply path may include a first supply path (e.g., tubes 25-28, 25a) connected to the sample placement member, and a second supply path (e.g., water absorbers 19, 19a, 19b, 19c, 19d) connecting the amplifying member and the test piece, wherein the amplifying member is disposed in the first supply path, and when the supply operating member is operated, the amplifying member is connected to the test piece via the second supply path.
[0277] In this device, the second supply channel may be disposed between the first supply channel and the test strip when the supply operating member is operated.
[0278] In this device, the second supply channel may be attached to one end of the test piece on the upstream side in the supply direction of the amplified nucleic acid (for example, one end of the chromatography paper 29b, 29c, 29d on the upstream side).
[0279] In the present device, the second supply path may be disposed between the amplifying member and the supply operation member.
[0280] In this device, the supply operating member may be disposed above the amplifying member, and the second supply path may be pressed by the supply operating member toward the amplifying member when the supply operating member is operated.
[0281] The device may also include a connecting member (e.g., connecting member 35) that connects the amplifying member and the supply operating member, and the amplifying member connected to the connecting member may be connected to the second supply path when the supply operating member is operated.
[0282] The present device may comprise a mounting table (e.g., mounting tables 34b and 34c) on which the test piece is placed, and the one end may be positioned upstream of the upstream end of the mounting table (e.g., the upstream end of mounting tables 34b and 34c).
[0283] In this device, the supply operation member may be positioned downstream of the test piece in the supply direction of the amplified nucleic acid, and the second supply path may be pressed by the supply operation member toward the amplification member when the supply operation member is operated.
[0284] In this device, the supply operation member may be attached to the other downstream end of the test strip (for example, the other downstream end of the chromatography paper 29d).
[0285] The present device may comprise a housing (e.g., a cover 10, 10a, a base 20, 20a) that houses the sample placement member, the test piece, the supply path, and the amplification member, and the housing may comprise insertion holes (e.g., an upper heater insertion hole 11, a lower heater insertion hole 21) into which heating means (e.g., a heater 30, an upper heater 31, a lower heater 32) that heats the first supply path is inserted.
[0286] The present device may comprise a housing that houses the sample placement member, the test piece, and the amplification member, wherein a portion of the first supply path is housed in the housing, and another portion of the first supply path is exposed to the outside of the housing so that it can be heated by a heating means.
[0287] In this device, the housing may include a sample introduction hole (e.g., sample introduction hole 17, 17a) through which the sample to be placed on the sample placement member is introduced, and a sealing member (e.g., cap 12, 12a) that seals the sample introduction hole, and when the sample introduction hole is not sealed with the sealing member, the inside of the housing is in communication with the outside of the housing only via the sample introduction hole.
[0288] In this device, the housing may include an observation window (e.g., second window 16) that allows the test piece to be viewed from outside the housing.
[0289] In this device, the test strip may have a color-developing surface that develops color when the amplified nucleic acid is captured, and the observation window may be positioned on the housing opposite the color-developing surface.
[0290] The device may comprise a developer tank (e.g., developer tank 18, 18a) that stores developer liquid for supplying the amplified nucleic acid toward the test piece, and a release means (e.g., first button 13, 13a, needle 23, 23a) that releases the developer liquid from the developer liquid tank, and when the release means is operated, the developer liquid is supplied to the supply path.
[0291] In this device, the release means may comprise a movement operating member (e.g., first button 13) that moves the developing liquid tank, and a breaking member (e.g., needle 23, 23a) that breaks a part of the developing liquid tank when the movement operating member is operated to move the developing liquid tank.
[0292] In the present device, the first supply path may be a tubular body, and the amplifying member may be disposed inside the tubular body.
[0293] In this device, the amplifying member may be a wire, and the tubular member may have a first opening (e.g., first opening 251-281) arranged on the sample placement member side, and a second opening (e.g., second opening 252-282) arranged on the test piece side, and one end of the amplifying member (e.g., one end 501-531, 501a) may be arranged on the first opening side, and the other end of the amplifying member (e.g., other end 502-532, 502a) may be arranged on the second opening side.
[0294] In the present device, one end of the amplifying member may be exposed to the outside of the tubular body through the first opening, and the other end of the amplifying member may be exposed to the outside of the tubular body through the second opening.
[0295] In this device, the amplification member may include a carrier that carries the reagent.
[0296] In the present device, the carrier may be a fiber assembly.
[0297] In this device, the reagent may include a first reagent that amplifies the nucleic acid and a second reagent that amplifies the nucleic acid; the wire may include a first wire that is disposed inside the tubular body and a second wire that is disposed inside the tubular body; the first reagent may be immobilized on the first wire, and the second reagent may be immobilized on the second wire.
[0298] In the present device, the tubular body may include a first tubular body in which the first wire body is arranged, and a second tubular body in which the second wire body is arranged.
[0299] In this device, the target nucleic acid may include a first nucleic acid and a second nucleic acid, the first reagent may amplify the first nucleic acid, and the second reagent may amplify the second nucleic acid.
[0300] The device may comprise a coloring agent that binds to the amplified nucleic acid, wherein the coloring agent includes: a first coloring agent that binds to a first amplified nucleic acid produced by amplifying the first nucleic acid; and a second coloring agent that binds to a second amplified nucleic acid produced by amplifying the second nucleic acid.
[0301] The device may comprise a capture agent that captures the amplified nucleic acid bound to the color developer, wherein the capture agent includes a first capture agent that captures the amplified nucleic acid bound to the first color developer, and a second capture agent that captures the amplified nucleic acid bound to the second color developer.
[0302] In this device, the capture agent may be disposed on the test strip, and the position of the first capture agent on the test strip may be different from the position of the second capture agent on the test strip.
[0303] In this device, at least one of the developer that supplies the amplified nucleic acid toward the test piece, the supply channel, and the test piece may be provided with the color developer.
[0304] In this device, the detection solution containing the amplified nucleic acid produced by contact between the sample and the reagent is supplied to the second supply path, and the second supply path has a first contact portion (e.g., first contact portion 191, 191a) that contacts the amplification member and a second contact portion (e.g., second contact portion 192, 192a) that contacts the test piece, and the detection solution may be supplied from the first contact portion to the second supply path and then supplied to the test piece from the second contact portion.
[0305] In this device, the second supply path may be a water absorbent body (e.g., water absorbent body 19, 19a) capable of absorbing the detection liquid, and the detection liquid absorbed by the water absorbent body may be supplied to the test piece when the supply operating member is operated and the water absorbent body is positioned between the first supply path and the test piece.
[0306] ●Characteristics of the present method The present method is a detection method using a detection device (e.g., present device 1, 1a) that detects amplified nucleic acid generated from a target nucleic acid contained in a sample, and the detection device comprises: a sample placement member (e.g., sample receiver 22, 22a) on which the sample is placed; a test strip (e.g., chromatography paper 29, 29a) used for detecting the amplified nucleic acid; an amplification member (e.g., amplification member 50-53, 50a) on which a reagent used to generate the amplified nucleic acid from the target nucleic acid is immobilized; and a supply path (e.g., water absorbent 19, 19a, tube 25-28, 25a) that supplies the amplified nucleic acid to the test strip, and the amplification member is placed in the supply path, and the detection method is characterized by comprising: a placement step in which the sample is placed on the sample placement member; a generation step in which the amplified nucleic acid is generated in the supply path; and a detection step in which the amplified nucleic acid is detected on the test strip.
[0307] In this method, the generating step may include a heating step in which the sample is heated.
[0308] In this method, the detection step may include a supply step of supplying a detection solution containing the amplified nucleic acid from the supply channel to the test piece.
[0309] ●Features of the present heating device The present heating device comprises a heating housing (e.g., heating housing 601) that houses a detection device that detects amplified nucleic acid generated from target nucleic acid contained in a sample, a heating unit (e.g., heating unit 602) that heats the target nucleic acid, and a heating start member (e.g., heating start button 603) that causes the heating unit to heat the target nucleic acid, and is characterized in that the heating unit heats the target nucleic acid for a predetermined time when the heating start member is operated.
[0310] In the present warming device, the detection device may be the present device (e.g., the present device 1, 1a).
[0311] REFERENCE SIGNS LIST 1 Detector 10 Cover (housing) 11 Upper heater insertion hole 12 Cap (sealing member) 13 First button (movement operation member) 14 First window (amplification observation window) 15 Second button (supply operation member) 16 Second window (detection observation window) 17 Sample introduction hole 18 Developer tank 19 Water absorber (second supply channel) 191 First contact portion 192 Second contact portion 20 Base (housing) 21 Lower heater insertion hole 22 Sample receiver (sample placement member) 23 Needle (breaking member) 24 Tube attachment member 25 Soft tube (first supply channel) 26 Soft tube (first supply channel) 27 Soft tube (first supply channel) 28 Soft tube (first supply channel) 251 First opening 261 First opening 271 First opening 281 First opening 252 Second opening 262 Second opening 272 Second opening 282 Second opening 29 Chromatography paper (test strip) 30 Heater 31 Upper heater 32 Lower heater 33 Power connector 40 Power supply 50 Amplifying member 51 Amplifying member 52 Amplifying member 53 Amplifying member 501 One end 511 One end 521 One end 531 One end 502 Other end 512 Other end 522 Other end 532 Other end 1a Detecting device 10a Cover (housing) 12a Cap (sealing member) 13a First button (movement operating member) 15a Second button (supply operating member) 17a Sample introduction hole 18a Developer tank 19a Water absorbent body (second supply channel) 191a First contact portion 192a Second contact portion 20a Base (housing) 22a Sample receiver (sample placement member) 23a Needle (breaking member) 25a Soft tube (first supply path) 29a Chromatography paper (test piece) 30a Heater 31a Upper heater 32a Lower heater 50a Amplifying member 501a One end 502a Other end 15b Second button (supply operation member) 19b Water absorbent body (second supply path) 29b Chromatography paper (test piece) 34b Mounting table15c Second button (supply operation member) 19c Water absorbent body (second supply path) 29c Chromatography paper (test strip) 34c Placement base 35 Connecting member 15d Second button (supply operation member) 19d Water absorbent body (second supply path) 29d Chromatography paper (test strip) 60 Heating device 601 Heating housing 6011 First housing 6012 Second housing 6013 Third housing 602 Heating section 603 Heating start button (heating start member) 604 Motor 6041 Motor rotating shaft 6041g Gear section 605 First button pressing section 6051 First pressing section 605g Gear section 606 Second button pressing section 6061 Second pressing section 606g Gear section
Claims
1. A detection device for detecting amplified nucleic acid generated from a target nucleic acid contained in a sample, comprising: a sample placement member on which the sample is placed; a test piece used for detecting the amplified nucleic acid; an amplification member on which a reagent used to generate the amplified nucleic acid from the target nucleic acid is immobilized; and a supply path for supplying the amplified nucleic acid toward the test piece, wherein the amplification member is placed in the supply path.
2. The detection device according to claim 1, further comprising: a supply operation member for supplying the amplified nucleic acid to the test piece, wherein the amplified nucleic acid is supplied to the test piece when the supply operation member is operated.
3. The detection device according to claim 2, wherein the amplifying member is connected to the test piece when the supply operating member is operated.
4. The detection device according to claim 3, wherein the test piece is disposed between the amplifying member and the supply operation member.
5. The detection device according to claim 4, wherein the supply operation member is disposed above the amplification member.
6. The detection device according to claim 4, wherein the supply operation member is disposed downstream of the test piece in the supply direction of the amplified nucleic acid.
7. A detection device as described in claim 3, wherein the supply path includes a first supply path connected to the sample placement member and a second supply path connecting the amplification member and the test piece, the amplification member is disposed in the first supply path, and the amplification member is connected to the test piece via the second supply path when the supply operation member is operated.
8. The detection device according to claim 7, wherein the second supply passage is disposed between the first supply passage and the test piece when the supply operating member is operated.
9. The detection device according to claim 7, wherein the second supply channel is attached to one end of the test piece on the upstream side in the supply direction of the amplified nucleic acid.
10. The detection device according to claim 9, wherein the second supply path is disposed between the amplifying member and the supply operation member.
11. The detection device according to claim 10, wherein the supply operation member is disposed above the amplifying member, and the second supply path is pressed by the supply operation member toward the amplifying member when the supply operation member is operated.
12. The detection device according to claim 10, further comprising: a connecting member that connects the amplifying member and the supply operation member; and the amplifying member connected to the connecting member is connected to the second supply path when the supply operation member is operated.
13. The detection device according to claim 11 or 12, further comprising: a mounting table on which the test piece is placed, and the one end is disposed upstream of the upstream end of the mounting table.
14. A detection device as described in claim 10, wherein the supply operation member is positioned downstream of the test piece in the supply direction of the amplified nucleic acid, and the second supply path is pressed by the supply operation member toward the amplification member when the supply operation member is operated.
15. The detection device according to claim 14, wherein the supply operation member is attached to the other downstream end of the test piece.
16. A detection device as described in claim 8, comprising: a housing that houses the sample placement member, the test piece, the supply path, and the amplification member, the housing having an insertion hole into which a heating means for heating the first supply path is inserted.
17. A detection device as described in claim 8, comprising: a housing that houses the sample placement member, the test piece, and the amplification member; a portion of the first supply path is housed in the housing; and another portion of the first supply path is exposed to the outside of the housing so as to be capable of being heated by a heating means.
18. A detection device as described in claim 16 or 17, wherein the housing comprises a sample introduction hole through which the sample placed on the sample placement member is introduced, and a sealing member that seals the sample introduction hole, and when the sample introduction hole is not sealed with the sealing member, the inside of the housing is connected to the outside of the housing only via the sample introduction hole.
19. A detection device as claimed in claim 16 or 17, wherein the housing is provided with an observation window that allows the test piece to be viewed from outside the housing.
20. A detection device as described in claim 19, wherein the test piece has a color-producing surface that produces a color when the amplified nucleic acid is captured, and the observation window is positioned in the housing opposite the color-producing surface.
21. A detection device as described in claim 1, comprising: a developer tank for storing a developer liquid for supplying the amplified nucleic acid toward the test piece; and a release means for releasing the developer liquid from the developer liquid tank, wherein when the release means is operated, the developer liquid is supplied to the supply path.
22. A detection device as described in claim 21, wherein the release means comprises: a movement operating member that moves the developing liquid tank; and a breaking member that breaks a part of the developing liquid tank when the movement operating member is operated to move the developing liquid tank.
23. The detection device according to claim 18, wherein a developing solution for supplying the amplified nucleic acid toward the test piece is introduced through the sample introduction hole.
24. The detection device according to claim 8, wherein the first supply path is a tube, and the amplifying member is disposed inside the tube.
25. A detection device as described in claim 24, wherein the amplifying member is a wire, and the tubular body has a first opening arranged on the sample placement member side and a second opening arranged on the test piece side, one end of the amplifying member is arranged on the first opening side, and the other end of the amplifying member is arranged on the second opening side.
26. A detection device as claimed in claim 25, wherein one end of said amplifying member is exposed to the outside of said tubular body through said first opening, and the other end of said amplifying member is exposed to the outside of said tubular body through said second opening.
27. The detection device according to claim 26, wherein the amplification member comprises a carrier that carries the reagent.
28. The detection device according to claim 27, wherein the carrier is a fiber assembly.
29. The detection device as described in claim 25, wherein the reagent includes a first reagent that amplifies the target nucleic acid and a second reagent that amplifies the target nucleic acid, the wire includes a first wire that is disposed inside the tubular body and a second wire that is disposed inside the tubular body, the first reagent is immobilized to the first wire, and the second reagent is immobilized to the second wire.
30. The detection device according to claim 29, wherein the tube includes: a first tube in which the first line is disposed; and a second tube in which the second line is disposed.
31. The detection device according to claim 29, wherein the target nucleic acid includes a first nucleic acid and a second nucleic acid, the first reagent amplifies the first nucleic acid, and the second reagent amplifies the second nucleic acid.
32. The detection device according to claim 31, comprising a color developer which binds to the amplified nucleic acid, the color developer comprising: a first color developer which binds to a first amplified nucleic acid produced by amplifying the first nucleic acid; and a second color developer which binds to a second amplified nucleic acid produced by amplifying the second nucleic acid.
33. The detection device according to claim 32, comprising a capture agent that captures the amplified nucleic acid bound to the color developer, the capture agent comprising: a first capture agent that captures the amplified nucleic acid bound to the first color developer; and a second capture agent that captures the amplified nucleic acid bound to the second color developer.
34. The detection device of claim 33, wherein the capture agent is disposed on the test strip, and the position of the first capture agent on the test strip is different from the position of the second capture agent on the test strip.
35. The detection device according to claim 34, wherein at least one of the developer that supplies the amplified nucleic acid toward the test piece, the supply channel, and the test piece is provided with the color developer.
36. A detection device as described in claim 8, wherein a detection solution containing the amplified nucleic acid produced by contact between the sample and the reagent is supplied to the second supply path, the second supply path having a first contact portion that contacts the amplification member and a second contact portion that contacts the test piece, and the detection solution is supplied from the first contact portion to the second supply path and then supplied to the test piece from the second contact portion.
37. A detection device as described in claim 36, wherein the second supply path is an absorbent body capable of absorbing the detection liquid, and the detection liquid absorbed by the absorbent body is supplied to the test piece when the supply operating member is operated to position the absorbent body between the first supply path and the test piece.
38. A detection method using a detection device that detects amplified nucleic acid generated from a target nucleic acid contained in a sample, the detection device comprising: a sample placement member on which the sample is placed; a test strip used for detecting the amplified nucleic acid; an amplification member having immobilized thereon a reagent used to generate the amplified nucleic acid from the target nucleic acid; and a supply path that supplies the amplified nucleic acid toward the test strip, the amplification member being placed in the supply path; and the detection method comprising: a placement step in which the sample is placed on the sample placement member; a generation step in which the amplified nucleic acid is generated in the supply path; and a detection step in which the amplified nucleic acid is detected on the test strip.
39. The detection method according to claim 38, wherein the generating step includes a heating step in which the sample is heated.
40. The detection method according to claim 38, wherein the detection step includes a supply step of supplying a detection liquid containing the amplified nucleic acid from the supply channel to the test piece.
41. A heating device comprising: a heating housing that houses a detection device that detects amplified nucleic acid generated from a target nucleic acid contained in a sample; a heating unit that heats the target nucleic acid; and a heating initiation member that causes the heating unit to heat the target nucleic acid, wherein the heating unit heats the target nucleic acid for a predetermined period of time when the heating initiation member is operated.
42. The warming device according to claim 41, wherein the detection device is the detection device according to claim 1.
Citation Information
Patent Citations
Adhesive for skin application, hardened material, and adhesive tape for skin application
JP2022070662A
Microfluidic chip for DNA extraction and detection method
CN109576345A
Nucleic acid-extracting apparatus
JP2005295910A
Nucleic acid detection method, and nucleic acid detection kit
WO2009034842A1
